These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 17302777)

  • 1. McLeod phenotype without the McLeod syndrome.
    Walker RH; Danek A; Uttner I; Offner R; Reid M; Lee S
    Transfusion; 2007 Feb; 47(2):299-305. PubMed ID: 17302777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of a novel XK splice site mutation in a patient with McLeod syndrome.
    Arnaud L; Salachas F; Lucien N; Maisonobe T; Le Pennec PY; Babinet J; Cartron JP
    Transfusion; 2009 Mar; 49(3):479-84. PubMed ID: 19040496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic variation among brothers with the McLeod neuroacanthocytosis syndrome.
    Walker RH; Jung HH; Tison F; Lee S; Danek A
    Mov Disord; 2007 Jan; 22(2):244-8. PubMed ID: 17133513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. McLeod phenotype associated with a XK missense mutation without hematologic, neuromuscular, or cerebral involvement.
    Jung HH; Hergersberg M; Vogt M; Pahnke J; Treyer V; Röthlisberger B; Kollias SS; Russo D; Frey BM
    Transfusion; 2003 Jul; 43(7):928-38. PubMed ID: 12823753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A McLeod phenotype detected by random screening for K:-4 [Kp(b-)] blood donors in Brazil.
    Wendel S; Fontão-Wendel R; Levi JE; Aravechia MG; Bordokan RF; Russo D; Haddad MS
    Transfusion; 2004 Nov; 44(11):1579-87. PubMed ID: 15504163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A family with McLeod syndrome and calpainopathy with clinically overlapping diseases.
    Starling A; Schlesinger D; Kok F; Passos-Bueno MR; Vainzof M; Zatz M
    Neurology; 2005 Dec; 65(11):1832-3. PubMed ID: 16344536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Kell and XK proteins of the Kell blood group are not co-expressed in the central nervous system.
    Clapéron A; Hattab C; Armand V; Trottier S; Bertrand O; Ouimet T
    Brain Res; 2007 May; 1147():12-24. PubMed ID: 17379193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic variability of a distinct deletion in McLeod syndrome.
    Miranda M; Castiglioni C; Frey BM; Hergersberg M; Danek A; Jung HH
    Mov Disord; 2007 Jul; 22(9):1358-61. PubMed ID: 17469188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. McLeod syndrome: a neurohaematological disorder.
    Jung HH; Danek A; Frey BM
    Vox Sang; 2007 Aug; 93(2):112-21. PubMed ID: 17683354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into extensive deletions around the XK locus associated with McLeod phenotype and characterization of two novel cases.
    Peng J; Redman CM; Wu X; Song X; Walker RH; Westhoff CM; Lee S
    Gene; 2007 May; 392(1-2):142-50. PubMed ID: 17300882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. McLeod syndrome resulting from a novel XK mutation.
    Singleton BK; Green CA; Renaud S; Fuhr P; Poole J; Daniels GL
    Br J Haematol; 2003 Aug; 122(4):682-5. PubMed ID: 12899725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two McLeod patients with novel mutations in XK.
    Dubielecka PM; Hwynn N; Sengun C; Lee S; Lomas-Francis C; Singer C; Fernandez HH; Walker RH
    J Neurol Sci; 2011 Jun; 305(1-2):160-4. PubMed ID: 21463873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion support for a patient with McLeod phenotype without chronic granulomatous disease and with antibodies to Kx and Km.
    Bansal I; Jeon HR; Hui SR; Calhoun BW; Manning DW; Kelly TJ; Lee S; Baron BW
    Vox Sang; 2008 Apr; 94(3):216-220. PubMed ID: 18167163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The McLeod syndrome without acanthocytes.
    Klempír J; Roth J; Zárubová K; Písacka M; Spacková N; Tilley L
    Parkinsonism Relat Disord; 2008; 14(4):364-6. PubMed ID: 17870653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. McLeod neuroacanthocytosis: genotype and phenotype.
    Danek A; Rubio JP; Rampoldi L; Ho M; Dobson-Stone C; Tison F; Symmans WA; Oechsner M; Kalckreuth W; Watt JM; Corbett AJ; Hamdalla HH; Marshall AG; Sutton I; Dotti MT; Malandrini A; Walker RH; Daniels G; Monaco AP
    Ann Neurol; 2001 Dec; 50(6):755-64. PubMed ID: 11761473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kell and XK immunohistochemistry in McLeod myopathy.
    Jung HH; Russo D; Redman C; Brandner S
    Muscle Nerve; 2001 Oct; 24(10):1346-51. PubMed ID: 11562915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point mutations causing the McLeod phenotype.
    Russo DC; Lee S; Reid ME; Redman CM
    Transfusion; 2002 Mar; 42(3):287-93. PubMed ID: 11961232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. McLeod myopathy revisited: more neurogenic and less benign.
    Hewer E; Danek A; Schoser BG; Miranda M; Reichard R; Castiglioni C; Oechsner M; Goebel HH; Heppner FL; Jung HH
    Brain; 2007 Dec; 130(Pt 12):3285-96. PubMed ID: 18055495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First example of anti-Kx in a person with the McLeod phenotype and without chronic granulomatous disease.
    Russo DC; Oyen R; Powell VI; Perry S; Hitchcock J; Redman CM; Reid ME
    Transfusion; 2000 Nov; 40(11):1371-5. PubMed ID: 11099667
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.